Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BJDX
BJDX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BJDX News
Bluejay Diagnostics Closes $8.5 Million Financing Round
Jun 06 2026
Newsfilter
Bluejay Diagnostics Secures $8.5 Million in Private Placement
Jun 03 2026
NASDAQ.COM
Bluejay Diagnostics Partners with Argonaut, Shares Surge 100%
Jun 03 2026
NASDAQ.COM
Bluejay Diagnostics Secures $8.5 Million Financing with Potential for $15.1 Million
Jun 02 2026
Newsfilter
Biotech Stocks Show Strong Pre-Market Moves
Jun 02 2026
NASDAQ.COM
Bluejay Diagnostics Partners with Argonaut to Enhance Symphony Platform
Jun 02 2026
NASDAQ.COM
Bluejay Partners with Argonaut to Enhance Manufacturing Capabilities
Jun 02 2026
Newsfilter
Bluejay Diagnostics Advances SYMON-II Trial Enrollment
Apr 07 2026
Newsfilter
NORTHSTRIVE FUND II: BLUEJAY BOARD ASSESSES A STRATEGIC OPPORTUNITY RECOMMENDATION
Mar 11 2026
moomoo
Bluejay Diagnostics Provides 2026 Strategic Update
Mar 06 2026
Newsfilter
Bluejay Diagnostics Fully Exercises All Prefunded Warrants
Feb 20 2026
Newsfilter
Etsy Sells Depop to eBay for $1.2 Billion
Feb 19 2026
Benzinga
Bluejay Diagnostics Enrolls 545 Patients in SYMON™ II Study
Feb 17 2026
Newsfilter
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Jan 27 2026
seekingalpha
Bluejay Diagnostics Completes Commercial Production of IL-6 Antibodies, Supporting 9 Million Symphony Cartridges
Dec 29 2025
Globenewswire
Bluejay Diagnostics Completes Commercial Production of IL-6 Antibodies, Supporting 9 Million Symphony Cartridges
Dec 29 2025
Newsfilter
Show More News
